PATENT CLAIM ANALYSIS

Application Number: 16014295
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["514", "210210"]

Abstract:
Provided are benzenesulfonamide derivatives or pharmaceutically acceptable salts thereof. Also provided is a method for treating cancer by using a pharmaceutical composition including the benzenesulfonamide derivatives or pharmaceutically acceptable salts thereof and pharmaceutically acceptable carriers.

Claim (Index 7):
The method of  claim 4 , wherein R 6  and R 7  in the benzenesulfonamide derivative represented by formula (I) are independently selected from the group consisting of H, an unsubstituted or substituted C 3 -C 6  cycloalkyl group and an unsubstituted or substituted C 3 -C 6  cycloheteroalkyl group, provided that R 6  and R 7  are not H at the same time, and wherein the substituted cycloalkyl group and the substituted cycloheteroalkyl group are independently substituted with a substituent selected from the group consisting of an amide group, a hydroxyl group, a benzyl group and an aminomethyl group.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.42308
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15387221', '15036384', '14361548', '14453502', '15566872']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7455103654040582
- 35 USC 102 Novelty (BERT): 0.4869385391745682
- Combined Prediction Score: 0.7196531827811092
- Mean Citation Score: 169.93924199999995
- Max Citation Score: 180.09967
- Similarity Product: 130.51661596069692

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test